Eyeworld

68 | EYEWORLD | SPRING 2025 R EFRACTIVE References 1. Rocha KM, et al. Tolerance to induced astigmatism with a monofocal intraocular lens designed to extend the dept of focus. J Refract Surg. 2023;39:222–228. 2. Xu Y, et al. Repeated low-level red light therapy for myopia control in high myopia children and adolescents: a randomized clinical trial. Ophthalmology. 2024;131:1314–1323. 3. Xiong R, et al. Myopia control effect of repeated low-level red-light therapy combined with orthokeratology: a multicenter randomized controlled trial. Ophthalmology. 2024;131:1304– 1313. 4. Wang F, et al. Repeated low-level red light therapy for the control of myopia in children: a meta-analysis of randomized controlled trials. Eye Contact Lens. 2023;49:438–446. by Karolinne Rocha, MD, PhD Refractive Editor O ur students, top of their class, understand the practical implica- tions of clinical research. What they learn with real-world application of their craft is that achiev- ing optimal visual outcomes plays a significant role in patient satisfaction. A personalized approach to lens selection and making the offer for premium technology are ways to meet the visual demands of your patients on the first try. A topic of my recently published research, 1 tolerance to refractive error (TRE) is higher in new generation IOLs, and thus the threshold for enhancement is improving. A currently underway prospective observational study aims to guide clinicians in improving postoperative visual quality by specifically targeting TRE. Learn more about this area of research at the ASCRS Annual Meeting, April 25–28 in Los Angeles, California, where my fellow and I will be presenting our study on the subject. Achieving the best visual outcome is also the topic of "Enhancement rates: what's accept- able and expected?" In it, John Berdahl, MD, and Lance Kugler, MD, lay out protocols for improving patient satisfaction after refractive surgery. Dr. Berdahl said he assesses topography, epithelial mapping, ocular surface optimization, and corneal SD-OCT before he considers an enhancement for the patient. He then employs a pair of temporary glasses with the new prescrip- tion to ensure the refractive outcome will meet the patient's needs. Also in the Refractive section of this issue, Roger Zaldivar, MD, discusses patient-reported outcome measures (PROMs) and their ability to provide data-based insights into experienc- es with premium IOLs and ICLs. I'm looking forward to seeing how PROMs can advance our ability to provide the best solutions to our patients. Addressing alarming prevalence rates of myopia in East Asia and Asian populations, Michael Repka, MD, lends us his insights in "Perspective on the current state of myopia and its control in the West." In the article, Dr. Repka speaks about therapeutic options, including an FDA-approved contact lens with two treatment zones that creates a myopic defocus to slow the progression of myopia in children aged 8–12. Information is advancing on additional thera- pies, such as high-add multifocal contact lenses, spectacle lenses, and red-light therapy. 2,3,4 It's an epidemic that requires our time and attention. With a wealth of education available, the ASCRS Annual Meeting offers a great oppor- tunity to learn more about how to meet and exceed patient expectations. I hope to see you in Los Angeles and especially for Refractive Day, taking place on April 25. Meet the visual demands of your patients A personalized approach to lens selection and making the offer for premium technology are two ways to meet the visual demands of your patients on the first try. William Trattler, MD, EyeWorld Refractive Editorial Board member, shared what he is excited for at the ASCRS Annual Meeting: "The ASCRS Annual Meeting is a true highlight of the year! I love how the meeting brings together so many of our colleagues, so it is a great opportunity to network as well as catch up with friends and classmates from training. I love exploring the Exhibit Hall and seeing the new innovations that have become available. And I love learning at the high-yield courses and symposia and often pick up helpful pearls that impact the way I care for patients." ASCRS ANNUAL MEETING P R E V I E W

• Cover